Fresenius Medical Care (FMC) St. Aktie
41,37
EUR
-0,15
EUR
-0,36
%
Kursziele der Fresenius Medical Care (FMC) St.-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Fresenius Medical Care (FMC) St.-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Goldman Sachs Group Inc. | 52,00 EUR | +24,82% | 18.11.2024 | |
| DZ BANK | - | - | 15.11.2024 | |
| UBS AG | 39,00 EUR | -6,39% | 12.11.2024 | |
| Deutsche Bank AG | 34,00 EUR | -18,39% | 06.11.2024 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 47,00 EUR | +12,82% | 06.11.2024 | |
| JP Morgan Chase & Co. | 37,30 EUR | -10,47% | 06.11.2024 | |
| Warburg Research | 31,00 EUR | -25,59% | 05.11.2024 | |
| Jefferies & Company Inc. | 29,00 EUR | -30,39% | 05.11.2024 | |
| Bernstein Research | 41,00 EUR | -1,58% | 05.11.2024 | |
| Barclays Capital | 38,50 EUR | -7,59% | 31.07.2024 | |
| Morgan Stanley | 33,00 EUR | -20,79% | 08.01.2024 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Baxter International Inc. | 0 | 0 | 0 | - | - |
| BB MEDTECH AG | 0 | 0 | 0 | - | - |
| Becton, Dickinson & Co. (BD) | 0 | 0 | 0 | - | - |
| Boston Scientific Corp. | 0 | 0 | 0 | - | - |
| Carl Zeiss Meditec AG | 1 | 5 | 3 | 67,88 EUR | +17,24% |
| DaVita HealthCare Partners Inc | 0 | 0 | 0 | - | - |
| Drägerwerk AG & Co. KGaA Vz. | 2 | 2 | 0 | 57,33 EUR | +33,17% |
| Fresenius Medical Care (FMC) St. | 2 | 5 | 4 | 37,88 EUR | -9,07% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 39,38 EUR | +20,43% |
| General Electric Co. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Medtronic PLC | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,62 CHF | +9,91% |
| Philips N.V. | 2 | 7 | 0 | 25,28 EUR | +3,35% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Siemens AG | 10 | 0 | 1 | 199,10 EUR | +12,59% |
| Smith & Nephew plc | 0 | 0 | 0 | - | - |
| St. Jude Medical Inc. | 0 | 0 | 0 | - | - |
| STRATEC SE | 1 | 4 | 0 | 40,00 EUR | +29,87% |
| Synthes Inc. | 0 | 0 | 0 | - | - |
| Zimmer Biomet | 0 | 0 | 0 | - | - |